Biofilm formation plays a key role in many bacteria causing infections, which mostly accounts for high-frequency infectious recurrence and antibiotics resistance. In this study, we sought to compare modified metabolism of biofilm and planktonic populations with UIT89, a predominant agent of urinary tract infection, by combining mass spectrometry based untargeted and targeted metabolomics methods, as well as cytological visualization, which enable us to identify the driven metabolites and associated metabolic pathways underlying biofilm formation. Surprisingly, our finding revealed distinct differences in both phenotypic morphology and metabolism between two patterns. Furthermore, we identified and characterized 38 differential metabolites and associated three metabolic pathways involving glycerolipid metabolism, amino acid metabolism and carbohydrate metabolism that were altered mostly during biofilm formation. This discovery in metabolic phenotyping permitted biofilm formation shall provide us a novel insight into the desperation of biofilm, which enable to develop novel biofilm based treatments against pathogen causing infections, with lower antibiotic resistance. 2013). UTI89 strain is a clinical UPEC strain that was originally isolated from the bladder of a woman with UTI, this stain is capable of forming a floating pellicle-biofilm in YESCA medium. To better understand the molecular phenotype of biofilm formation triggered by UPEC strain from a metabolic perspective, we aimed at investigate the biofilm formation by integrating staining assay, cytological observation with metabolomics method (Figure 1A).
Materials and MethodsReagents, Bacterial Strains and culture process. UTI89 was firstly incubated with LB broth ( Miller's LB)(BD, Franklin Lakes, USA). The biofilm formation culture was facilitated statically in YESCA medium (1% Calamine Acids and 0.12% yeast extract) in 96-well plastic plates for Congo red and crystal violet for staining, as well as conical flask for metabolite enrichment and extraction. Briefly, one colony UTI89 strain was incubated with 7ml LB broth for 5h on a shaker, and then the bacterial cells were diluted 100-fold into fresh YESCA medium, then incubated at 30° for 96 h statistically to trigger biofilm formation. The Congo red concentration was diluted in YESCA medium at 50ug/ml. All the reference compounds for targeted metabolite assay were purchased from Sigma Company (Sigma, St. Louis, USA) Crystal Violet Staining Assay. Biofilm formation was quantified by crystal violet staining assay. Biofilm was initiated as previous described. The mature biofilm was washed with PBS for 3 times and then fixed biofilm with methanol for 15 minutes.